129 related articles for article (PubMed ID: 31419642)
1. A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a.
Piacenti V; Langella E; Autiero I; Nolan JC; Piskareva O; Adamo MFA; Saviano M; Moccia M
Bioorg Chem; 2019 Oct; 91():103165. PubMed ID: 31419642
[TBL] [Abstract][Full Text] [Related]
2. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
[TBL] [Abstract][Full Text] [Related]
3. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights on Tiny Peptide Nucleic Acid (PNA) Analogues of miRNA-34a: An
Moccia M; Mercurio FA; Langella E; Piacenti V; Leone M; Adamo MFA; Saviano M
Front Chem; 2020; 8():568575. PubMed ID: 33330358
[TBL] [Abstract][Full Text] [Related]
5. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L
Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804
[TBL] [Abstract][Full Text] [Related]
6. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
[TBL] [Abstract][Full Text] [Related]
7. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM
Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116
[TBL] [Abstract][Full Text] [Related]
8. MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.
Beckers A; Van Peer G; Carter DR; Mets E; Althoff K; Cheung BB; Schulte JH; Mestdagh P; Vandesompele J; Marshall GM; De Preter K; Speleman F
Oncotarget; 2015 Mar; 6(7):5204-16. PubMed ID: 25294817
[TBL] [Abstract][Full Text] [Related]
9. microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.
He XY; Tan ZL; Mou Q; Liu FJ; Liu S; Yu CW; Zhu J; Lv LY; Zhang J; Wang S; Bao LM; Peng B; Zhao H; Zou L
Clin Cancer Res; 2017 Jun; 23(11):2905-2918. PubMed ID: 28003306
[No Abstract] [Full Text] [Related]
10. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
11. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
Haug BH; Hald ØH; Utnes P; Roth SA; Løkke C; Flægstad T; Einvik C
Anticancer Res; 2015 May; 35(5):2521-30. PubMed ID: 25964525
[TBL] [Abstract][Full Text] [Related]
12. MCPIP1 ribonuclease can bind and cleave
Nowak I; Boratyn E; Student S; Bernhart SF; Fallmann J; Durbas M; Stadler PF; Rokita H
RNA Biol; 2021 Jan; 18(1):144-156. PubMed ID: 32757706
[TBL] [Abstract][Full Text] [Related]
13. MYCN regulates oncogenic MicroRNAs in neuroblastoma.
Schulte JH; Horn S; Otto T; Samans B; Heukamp LC; Eilers UC; Krause M; Astrahantseff K; Klein-Hitpass L; Buettner R; Schramm A; Christiansen H; Eilers M; Eggert A; Berwanger B
Int J Cancer; 2008 Feb; 122(3):699-704. PubMed ID: 17943719
[TBL] [Abstract][Full Text] [Related]
14. Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis.
Zarrilli F; Amato F; Morgillo CM; Pinto B; Santarpia G; Borbone N; D'Errico S; Catalanotti B; Piccialli G; Castaldo G; Oliviero G
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698463
[TBL] [Abstract][Full Text] [Related]
15. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
[TBL] [Abstract][Full Text] [Related]
16. A Peptide Nucleic Acid (PNA) Masking the miR-145-5p Binding Site of the 3'UTR of the Cystic Fibrosis Transmembrane Conductance Regulator (
Sultan S; Rozzi A; Gasparello J; Manicardi A; Corradini R; Papi C; Finotti A; Lampronti I; Reali E; Cabrini G; Gambari R; Borgatti M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260566
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression.
Amato F; Tomaiuolo R; Nici F; Borbone N; Elce A; Catalanotti B; D'Errico S; Morgillo CM; De Rosa G; Mayol L; Piccialli G; Oliviero G; Castaldo G
Biomed Res Int; 2014; 2014():610718. PubMed ID: 24829907
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD.
Samaraweera L; Spengler BA; Ross RA
Oncol Rep; 2017 Jul; 38(1):545-550. PubMed ID: 28560387
[TBL] [Abstract][Full Text] [Related]
19. Towards diagnostic application of non-coding RNAs in neuroblastoma.
Althoff K; Schulte JH; Schramm A
Expert Rev Mol Diagn; 2016 Dec; 16(12):1307-1313. PubMed ID: 27813435
[TBL] [Abstract][Full Text] [Related]
20. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
Oh SY; Ju Y; Park H
Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
